Aralez Pharm Inc (ARLZQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,741 | -125,205 | -79,438 | -54,997 | -27,477 |
| Depreciation Amortization | 9,391 | 35,907 | 26,898 | 17,830 | 8,901 |
| Income taxes - deferred | -1,147 | 1,066 | N/A | 0 | N/A |
| Accounts receivable | -27,711 | 4,614 | 6,959 | 9,667 | 11,421 |
| Other Working Capital | 23,721 | 12,861 | 12,426 | 19,833 | 22,080 |
| Other Operating Activity | 34,064 | 41,971 | 13,964 | 3,555 | -4,437 |
| Operating Cash Flow | $18,577 | $-28,786 | $-19,191 | $-4,112 | $10,488 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -1,299 | -1,179 | -1,179 | -1,461 |
| Other Investing Activity | 0 | -215 | -215 | -216 | -215 |
| Investing Cash Flow | $-30 | $-1,514 | $-1,394 | $-1,395 | $-1,676 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 56 | 108 | 108 | 108 | 108 |
| Other Financing Activity | -3,424 | -6,341 | -4,137 | -3,977 | -125 |
| Financing Cash Flow | $-3,368 | $-6,233 | $-4,029 | $-3,869 | $-17 |
| Exchange Rate Effect | -184 | 482 | 402 | 209 | -9 |
| Beginning Cash Position | 28,892 | 64,943 | 64,943 | 64,943 | 64,943 |
| End Cash Position | 43,887 | 28,892 | 40,731 | 55,776 | 73,729 |
| Net Cash Flow | $14,995 | $-36,051 | $-24,212 | $-9,167 | $8,786 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,577 | -28,786 | -19,191 | -4,112 | 10,488 |
| Capital Expenditure | -32 | -1,822 | -1,702 | -1,702 | -1,461 |
| Free Cash Flow | 18,545 | -30,608 | -20,893 | -5,814 | 9,027 |